Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Intestine transplantation

An intestine transplant may involve the use of an entire intestine or just a shortened segment. Most intestine transplants completed in the United States have involved the transplant of the full organ and often are performed in conjunction with a liver transplant. Although most intestine transplants involve organs harvested from a deceased donor, recent advances in the field now have made it possible for living-donor intestinal segment transplants. There were 178 intestinal transplant recipients (171 deceased donors, 7 living donors) in 2005.3... [Pg.831]

Intestine Fever and Gl symptoms (e.g., bloating, cramping, diarrhea, increased stomal output) There are no reliable biochemical markers for intestine transplant rejection, but biopsies may be helpful... [Pg.834]

The mRNA expression of PEPT1 varies significantly in response to several chemical factors. The expression of the transporter was upregulated by substrates [89, 90], diet [91, 92], insulin [93], a2-adrenergic agonists [93], and pentazocine [94]. While it has been reported that intestinal transplantation [89, 95], cAMP [96], epidermal growth factor [97], and thyroid hormone [98] inhibited the expression of PEPT1. [Pg.253]

Chehade, M., Nowak-Wegrzyn, A., Kaufman, S. S., Fishbein, T. M., Tschemia, A., and FeFeiko, N. S. (2004). De novo food allergy after intestinal transplantation A report of three cases. /. Pediatr. Gastroenterol. Nutr. 38, 545-547. [Pg.170]

Intestinal transplantation is combined with liver transplantation in 46% of cases, because of terminal liver failure (93). Of 78 patients who had received parenteral nutrition for more than 2 years n — 66) and/ or had short bowel syndrome and could not be weaned from parenteral nutrition (n = 12), 58 developed chronic cholestasis and 37 developed one or more severe liver complication (serum bilirubin concentration 60 pmol/l, factor V (proaccelerin) 50%, portal hypertension, encephalopathy, ascites, bleeding from the gastrointestinal tract, or histological findings consisting of extensive fibrosis and cirrhosis) after 6 (3-132) months and 17 (2-155) months respectively. Liver disease was responsible for deaths in 6.5% of the patients (22% of deaths). [Pg.2710]

Attempts to minimize TAC-induced renal dysfunction by TAC switch to sirolimus [419, 744, 745] or use of low-dose maintenance TAC therapy associated with lymphocyte depleting agents, mycophenolate mofetil or sirolimus have been successfully achieved [746-750]. However, the association of TAC and sirolimus does not seem to be problem-free. Severe acute kidney injury in renal transplant recipients and thrombotic microangiopathy in intestinal transplant have been associated to combined use of TAC and sirolimus [751, 752], renal function improved in renal transplant recipients after conversion from TAC/ sirolimus to TAC/MMF therapy [753] and TAC/sirolimus combination was associated to worst renal allograft survival than TAC/MMF im-... [Pg.648]

Paramesh AS, Grosskreutz C, Florman SS, Gondolesi GE, Sharma S, Kaufman SS, Fishbein TM.Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation. Transplantation 2004 77 129-131. [Pg.680]

Berney T, Dehs S, Kato T, et al. Successful treatment of post-transplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients. Transplantation 2002 74 1000-1006. [Pg.1643]

Langnas AN, Shaw BW, Antonson DL, et al. Preliminary experience with intestinal transplantation in infants and children. Pediatrics 1996 97 443— 448. [Pg.2588]

Grant D. Intestinal transplantation 1997 report of the international registry. Intestinal Transplant Registry. Transplantation 1999 67 1061-1064. [Pg.2657]

Goulet O, et al. Intestinal transplantation Indications, results and strategy. Curr Opin Clin Nutr Metab Care 2000 3 329-338. [Pg.2657]

Deutsch AA, Arensman R, Levey R, Folkman J. The effect of antilymphocyte serum on fetal rat intestine transplanted as free subcutaneous homografts. J. Pediatr. Surg. 1974 9 29-34. [Pg.380]

Many etiologies for protein-losing enteropathies (celiac disease, intestinal lymphangiectasis, allergic gastroenteritis, cow milk protein allergy, Crohn disease, cystic fibrosis, collagen vascular disease, short bowel, intestinal transplants and others) have been identified. [Pg.184]

Puestow, C.B. 1933. Studies on the origins of the automaticity of the intestine the action of certain drugs on isolated intestinal transplants. Am. J. Physiol, 106 682-688. [Pg.104]

Deltz, E., Schroeder, R, Gebhardt, H., Gundlach, M., Engemann, R., Timmermann, W., 1989. First successful clinical small intestine transplantation. Tactics and surgical technic. Chirurg 60 (4), 235-239. [Pg.135]

Kiyochi, H., Ono, A., Yamamoto, N., Ohnishi, K., Shimahara, Y., and Kobayashi, N., Extrinsic sympathetic reinnervation after intestinal transplantation in rats, Tran.splan-tation, 59. 328-333 (1995). [Pg.1048]


See other pages where Intestine transplantation is mentioned: [Pg.830]    [Pg.831]    [Pg.846]    [Pg.273]    [Pg.154]    [Pg.1627]    [Pg.2589]    [Pg.2651]    [Pg.2651]    [Pg.446]    [Pg.121]    [Pg.1036]    [Pg.211]    [Pg.211]    [Pg.211]    [Pg.211]    [Pg.213]    [Pg.215]    [Pg.217]    [Pg.219]   
See also in sourсe #XX -- [ Pg.5 , Pg.487 ]




SEARCH



Intestinal transplantation

Short bowel syndrome intestinal transplantation

© 2024 chempedia.info